Journal
FITOTERAPIA
Volume 80, Issue 2, Pages 123-126Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.fitote.2008.12.002
Keywords
Stigmasterol; Thyroid hormones; Insulin; Lipid peroxidation
Categories
Funding
- Council of Scientific and Industrial Research (CSIR), New Delhi, India
Ask authors/readers for more resources
Stigmasterol, isolated from the bark of Butea monosperma was evaluated for its thyroid hormone and glucose regulatory efficacy in mice. Its administration at 2.6 mg/kg/d for 20 days reduced serum triiodothyronine (T-3), thyroxin (T-4) and glucose concentrations as well as the activity of hepatic glucose-6-phophatase (G-6-Pase) with a concomitant increase in insulin indicating its thyroid inhibiting and hypoglycemic properties. A decrease in the hepatic lipid peroxidation (LPO) and an increase in the activities of catalase (CAT), superoxide dismutase (SOD) and glutathione (GSH) suggested its antioxidative potential. The highest concentration tested (5.2 mg/kg) evoked pro-oxidative activity. (C) 2008 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available